Its leading investigational drug demonstrated relatively high levels of weight loss in a late-stage clinical trial.

The company is widening its participation in a U.S. Navy program to update countermeasures for military aircraft.

Vici Properties ( VICI +1.19%) is one of my favorite dividend stocks, and I've owned it for more than six years. To say that ...

This is reflected in Wall Street's outlook for the stock. Micron reported $75.52 in earnings per share during its fiscal 2026 ...

But if Anthropic attracts a lower valuation than expected for its upcoming IPO, it might not raise as much money as it ...

Amazon has multiple business lines, including fast-growing revenue streams from cloud and advertising services, but ...

Anthropic’s proposed $45 billion Nscale expansion could help fuel its growth, but it also adds another enormous bill ahead of ...

Throughout the initial public offering (IPO) process, Space Exploration Technologies ignored convention. Now, everyday ...

Marketing spend increases and AI-driven risk tools position Capital One to capture premium customers while synergies fuel ...

This has been a year of historic change for the trillion-dollar conglomerate that Warren Buffett built. Following the Oracle ...

Automation is decoupling earnings growth from economic headwinds, letting Neptune expand without adding staff.

But this year, as investors began to worry about companies that rely heavily on AI for growth, they returned to Apple. In ...